NCT02971488

The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 529 (actual)
• Sponsor: Hospital Universitario Infanta Leonor · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Screening, diagnosis and treatment of HCV in PWID, should be part of a harm reduction strategy. Treatment of HCV infected PWID should be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population. More frequent diagnosis, new methods that prevent loss of tracking, and access to antiviral treatment are all strategies that must be implemented jointly if the prevalence of HCV infection in our setting is to be reduced.

Conditions

• Hepatitis C
• Drug Users
• Harm Reduction
• HIV

Interventions

Type	Name	Description
OTHER	Screening for HCV in PWID and Linkage-To-Care	Screening, diagnosis and treatment of HCV in PWID, will be part of a harm reduction strategy. Treatment of HCV infected PWID will be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population.

Timeline

• Start date: 2017-01-15
• Primary completion: 2018-12-31
• Completion: 2019-05-10
• First posted: 2016-11-23
• Last updated: 2019-09-13
• Results posted: 2019-09-13